Maria Fernada Albuja Altamirano (@mafer_aa95) 's Twitter Profile
Maria Fernada Albuja Altamirano

@mafer_aa95

MD 👩🏻‍⚕| IMG 🇪🇨 | Latina | Passionate for🩸 disorders -Heme/Onc overlap- Ca thrombosis, SCD, ITP | HIP Awardee | Heme-Onc 🫶💭✨| IM PGY-2 Lincoln Hospital🗽

ID: 507649139

linkhttps://home.projectimg.org/courses/hematology-oncology/53 calendar_today28-02-2012 17:16:38

202 Tweet

327 Followers

740 Following

Lincoln Medical Center IM Residency Program (@lincolndepmed) 's Twitter Profile Photo

Dr. Yula Danova (pgy2) being both a teacher and IV mannequin (living) to our medical student… amazing dedication to teaching!! #imlincoln #internalmedicineresidency

Dr. Yula Danova (pgy2) being both a teacher and IV mannequin (living) to our medical student… amazing dedication to teaching!! 

#imlincoln #internalmedicineresidency
American College of Cardiology (@accintouch) 's Twitter Profile Photo

The PROACT trial found adding enalapril to standard care during chemotherapy did not prevent cardiotoxicity in patients receiving high-dose anthracycline-based chemotherapy. Read more on the trial: bit.ly/3ZnZWiV #ACCLATAM

The PROACT trial found adding enalapril to standard care during chemotherapy did not prevent cardiotoxicity in patients receiving high-dose anthracycline-based chemotherapy.

Read more on the trial: bit.ly/3ZnZWiV #ACCLATAM
American College of Cardiology (@accintouch) 's Twitter Profile Photo

The ULTIMATE-DAPT trial showed that compared w/ standard 12-month DAPT with aspirin and ticagrelor, 1-month DAPT followed by de-escalation to ticagrelor monotherapy reduces bleeding without an increase in ischemic events at 1 year among patients undergoing PCI for ACS. Get the

The ULTIMATE-DAPT trial showed that compared w/ standard 12-month DAPT with aspirin and ticagrelor, 1-month DAPT followed by de-escalation to ticagrelor monotherapy reduces bleeding without an increase in ischemic events at 1 year among patients undergoing PCI for ACS. Get the
H.O.M.E (@hemeoncfellow) 's Twitter Profile Photo

Every year we see the SAME faces at major conferences. The #hemeonc community has PLENTY of talented physicians waiting for the right plattform to share their work.We urge ALL conference chairs to ensure that agendas are purposefully planned ensuring equal opportunity for all ♥️

Every year we see the SAME faces at major conferences. The #hemeonc community has PLENTY of talented physicians  waiting for the right plattform to share their work.We urge ALL conference chairs to ensure that agendas are purposefully planned ensuring equal opportunity for all ♥️
Juan Martinez Ortega (@jmartinezo93) 's Twitter Profile Photo

Starting with our recently graduated Pulm-Crit attending, fellows, residents, and med students! Lincoln is in the house. 🫡 🫁 ❤️CHEST! #CHEST2024 #chestsome Lincoln Medical Center IM Residency Program CHEST

Starting with our recently graduated Pulm-Crit attending, fellows, residents, and med students! Lincoln is in the house. 🫡 🫁 ❤️CHEST! 
#CHEST2024 #chestsome 
<a href="/lincolndepmed/">Lincoln Medical Center IM Residency Program</a> <a href="/accpchest/">CHEST</a>
Daniel Gonzalez-Mosquera (@dgonzalezmmd) 's Twitter Profile Photo

“This little Ecuadorian is heading back to San Diego! 🇪🇨 Thrilled to share that one of my abstracts was accepted to #DDW2025 Can’t wait to see you all there!” #GI #DDW

“This little Ecuadorian is heading back to San Diego! 🇪🇨
Thrilled to share that one of my abstracts was accepted to #DDW2025
Can’t wait to see you all there!”
#GI #DDW
Javier Contreras Yametti (@javiercyametti) 's Twitter Profile Photo

Unfortunately, I didn’t match, but I’m approaching SOAP with the same hope and determination. Any advice or guidance would be greatly appreciated! Congratulations to all my colleagues!! #Match2025 #MatchDay #SOAP2025

Unfortunately, I didn’t match, but I’m approaching SOAP with the same hope and determination. Any advice or guidance would be greatly appreciated!
Congratulations to all my colleagues!! 
#Match2025 #MatchDay #SOAP2025
Javier Contreras Yametti (@javiercyametti) 's Twitter Profile Photo

This week has been an emotional rollercoaster. I have felt the warm support of family, friends, and colleagues. I’m thrilled to start my Transitional Year at @MetroWestMedCtr and already looking forward to the next chapter. Thank you all for your support! #MATCH25

This week has been an emotional rollercoaster. I have felt the warm support of family, friends, and colleagues.

I’m thrilled to start my Transitional Year at @MetroWestMedCtr and already looking forward to the next chapter.

Thank you all for your support!
#MATCH25
FDA Oncology (@fdaoncology) 's Twitter Profile Photo

FDA approves a treatment for adults with resectable locally advanced head and neck squamous cell cancer whose tumors express PD-L1. fda.gov/drugs/resource…

FDA approves a treatment for adults with resectable locally advanced head and neck squamous cell cancer whose tumors express PD-L1. fda.gov/drugs/resource…
Thrombosis & Haemostasis, TH,TH Open (@th_journal) 's Twitter Profile Photo

💊 DOAC for Prevention of Venous Thromboembolism after #cancer-related surgery: a Network Meta-analysis ⬇️ 📌 Pititto et al. included 5 RCTs and found that #DOAC reduced #VTE without increase in bleeding Read more: 👉 thieme-connect.com/products/ejour… #anticoagulant #thrombosis

💊 DOAC for Prevention of Venous Thromboembolism after #cancer-related surgery: a Network Meta-analysis ⬇️

📌 Pititto et al. included 5 RCTs and found that #DOAC reduced #VTE without increase in bleeding

Read more: 👉 thieme-connect.com/products/ejour…

#anticoagulant #thrombosis
Blood Journal (@bloodjournal) 's Twitter Profile Photo

The combination of corticosteroids, IV immunoglobulin, and platelet transfusion was the most common treatment for critical ITP bleeding. ow.ly/rrsS50Wnc6y #healthservicesandoutcomes #plateletsandthrombopoiesis

The combination of corticosteroids, IV immunoglobulin, and platelet transfusion was the most common treatment for critical ITP bleeding. ow.ly/rrsS50Wnc6y #healthservicesandoutcomes #plateletsandthrombopoiesis